文献速递结核与非结核分枝杆菌

全基因组测序评估印度糖尿病对结核分枝杆菌突变及复发类型的影响

Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India.
PubMed 文献 · Clin Infect Dis · 2022-01-01

本研究嵌套于印度3项结核病患者(伴或不伴糖尿病)队列研究,对基线与治疗失败/复发时的成对结核分枝杆菌分离株行全基因组测序,比较单核苷酸多态性(SNP)获得率、耐药突变及复发类型。结果显示复发时糖尿病组SNP获得率显著高于单纯结核组(1.28 vs 0.21/人年,P=0.02),治疗失败时无显著差异,约四分之一糖尿病复发患者为外源性再感染。

要点

  • 复发时糖尿病组SNP获得率为1.28/人年,显著高于单纯结核组的0.21/人年(P=0.02)。
  • 治疗失败时糖尿病组与单纯结核组SNP获得率无显著差异。
  • 复发时外源性再感染率糖尿病组为25%(3/12),单纯结核组为17%(4/24),P=0.66。

核心结论

  • 印度糖尿病患者复发时存在相当高的宿主内结核分枝杆菌突变率,且四分之一糖尿病复发患者为外源性再感染。

研究设计与样本

  • 本研究嵌套于印度3项结核病患者(伴或不伴糖尿病)队列研究。
  • 对基线与治疗失败/复发时成对结核分枝杆菌分离株行全基因组测序。
  • 3项母队列共纳入1633例,236例(14.5%)有微生物学确诊的治疗失败/复发,76对分离株可用于测序(糖尿病组22对,单纯结核组54对)。

主要发现

  • 总体SNP获得率为0.43(95%CI 0.25-0.64)/人年;治疗失败时为0.77(95%CI 0.40-1.35)/人年,复发时为0.44(95%CI 0.19-0.86)/人年。
  • 复发时糖尿病组SNP获得率为1.28(95%CI 0.41-2.98)/人年,单纯结核组为0.21(95%CI 0.04-0.61)/人年,差异显著(P=0.02)。
  • 治疗失败时糖尿病组与单纯结核组SNP获得率无显著差异。
  • 获得性结核耐药:糖尿病组4/18(22%),单纯结核组4/45(9%),P=0.21。
  • 13例(17%)发生外源性再感染;复发时再感染率糖尿病组为25%(3/12),单纯结核组为17%(4/24),P=0.66。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence describing the impact of diabetes mellitus (DM) on the recurrence and mutation rate of Mycobacterium tuberculosis (Mtb) is limited. METHODS: This study was nested in 3 cohort studies of tuberculosis (TB) patients with and without DM in India. Paired Mtb isolates recovered at baseline and treatment failure/recurrence underwent whole genome sequencing. We compared acquisition of single-nucleotide polymorphisms (SNPs), TB drug resistance mutations, and type of recurrence (endogenous reactivation [<8 SNPs] or exogenous reinfection [≥8 SNPs]) by DM status. RESULTS: Of 1633 enrolled in the 3 parent cohorts, 236 (14.5%) had microbiologically confirmed TB treatment failure/recurrence; 76 Mtb isolate pairs were available for sequencing (22 in TB-DM and 54 in TB-only). The SNP acquisition rate was overall was 0.43 (95% confidence interval [CI], .25-.64) per 1 person-year (PY); 0.77 (95% CI, .40-1.35) per 1 PY, and 0.44 (95% CI, .19-.86) per 1 PY at treatment failure and recurrence, respectively. Significant difference in SNP rates by DM status was seen at recurrence (0.21 [95% CI, .04-.61]) per 1 PY for TB-only vs 1.28 (95% CI, .41-2.98) per 1 PY for TB-DM; P = .02). No significant difference in SNP rates by DM status was observed at treatment failure. Acquired TB drug resistance was seen in 4 of 18 (22%) in TB-DM vs 4 of 45 (9%) in TB-only (P = .21). Thirteen (17%) participants had exogenous reinfection; the reinfection rate at recurrence was 25% (3/12) for TB-DM vs 17% (4/24) in TB-only (P = .66). CONCLUSIONS: Considerable intrahost Mtb mutation rates were present at recurrence among patients with DM in India. One-fourth of patients with DM had exogenous reinfection at recurrence.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Mave V, Chen L, Ranganathan UD, et al. Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India. Clin Infect Dis. 2022. PMID: 34984435. doi:10.1093/cid/ciab1067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。